What are the guidelines for managing diabetic ketoacidosis (DKA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Diabetic Ketoacidosis

Begin immediate treatment with isotonic saline at 15-20 mL/kg/hour for the first hour, followed by continuous intravenous regular insulin at 0.1 units/kg/hour once potassium is ≥3.3 mEq/L, and continue insulin until complete resolution of ketoacidosis regardless of glucose levels. 1

Diagnostic Criteria

DKA is confirmed when all three criteria are present: 1, 2

  • Blood glucose >250 mg/dL (though euglycemic DKA can occur, particularly with SGLT2 inhibitors)
  • Arterial pH <7.3 and serum bicarbonate <15 mEq/L
  • Presence of ketonemia or ketonuria with elevated anion gap

Initial Laboratory Assessment

Obtain the following tests immediately: 1

  • Plasma glucose, blood urea nitrogen, creatinine, serum ketones
  • Electrolytes with calculated anion gap, osmolality
  • Arterial blood gases, complete blood count with differential
  • Urinalysis, urine ketones, electrocardiogram
  • Bacterial cultures (blood, urine, throat) if infection suspected 1

Direct measurement of β-hydroxybutyrate in blood is the preferred monitoring method, as nitroprusside only detects acetoacetic acid and acetone. 1

Fluid Resuscitation

Start with isotonic saline (0.9% NaCl) at 15-20 mL/kg/hour (approximately 1-1.5 L) during the first hour to restore tissue perfusion and improve insulin sensitivity. 1 This aggressive initial fluid replacement is critical for treatment success. 1

After the first hour, adjust fluid choice based on: 1

  • Hydration status
  • Serum electrolyte levels
  • Urine output

When serum glucose reaches 250 mg/dL, switch to 5% dextrose with 0.45-0.75% NaCl while continuing insulin therapy to prevent hypoglycemia and allow complete clearance of ketones. 1 This is a critical step—failure to add dextrose is a common cause of persistent ketoacidosis. 1

Insulin Therapy

Initiation

Do NOT start insulin if potassium <3.3 mEq/L—correct hypokalemia first to prevent life-threatening arrhythmias and respiratory muscle weakness. 1 Despite potentially normal or elevated initial potassium levels, total body potassium depletion is universal in DKA. 1

Once potassium ≥3.3 mEq/L: 1

  • Start continuous IV regular insulin at 0.1 units/kg/hour (no bolus needed)
  • Target glucose decline of 50-75 mg/dL per hour
  • If glucose doesn't fall by 50 mg/dL in the first hour, check hydration; if adequate, double the insulin infusion rate hourly until steady decline achieved

Critical Insulin Management Principle

Continue insulin infusion until complete resolution of ketoacidosis (pH >7.3, bicarbonate ≥18 mEq/L, anion gap ≤12 mEq/L) regardless of glucose levels. 1 Premature termination of insulin before ketosis resolves is a leading cause of DKA recurrence. 1

Alternative for Mild-Moderate DKA

For uncomplicated mild-to-moderate DKA in alert patients, subcutaneous rapid-acting insulin analogs combined with aggressive fluid management are equally effective, safer, and more cost-effective than IV insulin. 1 However, continuous IV insulin remains standard for critically ill and mentally obtunded patients. 1

Electrolyte Management

Potassium Replacement

This is critical—inadequate potassium monitoring and replacement is a leading cause of DKA mortality. 1

Potassium replacement protocol: 1

  • If K+ <3.3 mEq/L: Hold insulin, aggressively replace potassium until ≥3.3 mEq/L
  • If K+ 3.3-5.5 mEq/L: Add 20-30 mEq/L potassium to IV fluids (use 2/3 KCl and 1/3 KPO₄) once adequate urine output confirmed
  • If K+ >5.5 mEq/L: Withhold potassium initially but monitor closely, as levels will drop rapidly with insulin therapy
  • Target serum potassium 4-5 mEq/L throughout treatment

Bicarbonate

Bicarbonate is NOT recommended for pH >6.9-7.0. 1 Studies show no benefit in resolution time or outcomes, and it may worsen ketosis, cause hypokalemia, and increase cerebral edema risk. 1

Monitoring During Treatment

Draw blood every 2-4 hours to measure: 1

  • Serum electrolytes, glucose, blood urea nitrogen, creatinine
  • Osmolality and venous pH (typically 0.03 units lower than arterial pH)
  • Anion gap to monitor acidosis resolution

Check blood glucose every 1-2 hours until stable, then every 4 hours. 3

Monitor for cerebral edema, particularly in children and with overly rapid osmolality correction (should not exceed 3 mOsm/kg/hour). 3

Resolution Criteria

DKA is resolved when ALL of the following are met: 1

  • Glucose <200 mg/dL
  • Serum bicarbonate ≥18 mEq/L
  • Venous pH >7.3
  • Anion gap ≤12 mEq/L

Target glucose 150-200 mg/dL until these resolution parameters are achieved. 1

Transition to Subcutaneous Insulin

Administer basal insulin (intermediate or long-acting) 2-4 hours BEFORE stopping IV insulin infusion to prevent recurrence of ketoacidosis and rebound hyperglycemia. 1 This overlap period is essential. 1

Once patient can eat, start multiple-dose schedule using combination of short/rapid-acting and intermediate/long-acting insulin. 1

Treatment of Precipitating Causes

Identify and treat underlying triggers: 1

  • Infection (most common—administer appropriate antibiotics)
  • Myocardial infarction, cerebrovascular accident
  • Insulin discontinuation or inadequacy
  • Pancreatitis, trauma
  • SGLT2 inhibitors must be discontinued 3-4 days before any planned surgery to prevent euglycemic DKA 1

Common Pitfalls to Avoid

Critical errors that lead to complications or treatment failure: 1

  • Interrupting insulin when glucose falls while ketoacidosis persists—this is a common cause of worsening ketosis
  • Failing to add dextrose when glucose <250 mg/dL while continuing insulin
  • Premature termination of insulin therapy before complete ketosis resolution
  • Inadequate potassium monitoring and replacement—a leading cause of mortality
  • Overzealous treatment without glucose supplementation leading to hypoglycemia
  • Overly rapid correction of osmolality (>3 mOsm/kg/hour) increasing cerebral edema risk

Discharge Planning

Before discharge, ensure: 1

  • Identification of outpatient diabetes care providers
  • Patient understanding of diabetes diagnosis and glucose monitoring
  • Knowledge of home glucose goals and when to call healthcare professional
  • Schedule follow-up appointments prior to discharge to increase attendance likelihood

References

Guideline

Assessment and Management of Diabetic Ketoacidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diabetic Ketoacidosis: Evaluation and Treatment.

American family physician, 2024

Guideline

Management of CO2 Retention in DKA with Reverse Takotsubo Cardiomyopathy and Pleural Effusion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.